Terms: = Uterine cancer AND COL1A1, P02452, 1277, ENSG00000108821, OI4 AND Prognosis
5 results:
1. Transcriptome analysis of an AKT inhibitor-resistant endometrial cancer cell line.
Onishi T; Takashima T; Shibahara K; Takagi S; Tanaka S; Mori M; Odashima H; Osawa Y; Hattori M
Pharmacol Rep; 2024 Apr; 76(2):379-389. PubMed ID: 38478219
[TBL] [Abstract] [Full Text] [Related]
2. col1a1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
Rota S; Franza A; Fabbroni C; Paolini B; Greco FG; Alessi A; Padovano B; Casali P; Sanfilippo R
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1969. PubMed ID: 38279510
[TBL] [Abstract] [Full Text] [Related]
3. col1a1-PDGFB Fusion Associated Fibrosarcoma of the uterine Corpus: A Case Report and Literature Review.
Panwar V; Liu Y; Gwin K; Chen H
Int J Gynecol Pathol; 2023 Mar; 42(2):143-146. PubMed ID: 36729934
[TBL] [Abstract] [Full Text] [Related]
4. Tandem mass tag-based quantitative proteomic analysis of cervical cancer.
Aljawad MF; Faisal AHMA; Alqanbar MF; Wilmarth PA; Hassan BQ
Proteomics Clin Appl; 2023 Jan; 17(1):e2100105. PubMed ID: 36029187
[TBL] [Abstract] [Full Text] [Related]
5. A gene interaction network‑based method to measure the common and heterogeneous mechanisms of gynecological cancer.
Wang M; Li L; Liu J; Wang J
Mol Med Rep; 2018 Jul; 18(1):230-242. PubMed ID: 29749503
[TBL] [Abstract] [Full Text] [Related]
